Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
-To evaluate the superiority of ERB-041 relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive-aged women using the Biberoglu & Behrman (B&B) scale administered by the physician investigator. -To compare the safety profile of ERB-041 with placebo during 12 weeks of treatment.
Inclusion criteria
- Reproductive-aged women with moderate to severe symptoms related to endometriosis. Subjects will have been diagnosed with endometriosis by laparoscopy or laparotomy within 10 years before visit 1B (screening)